1952 — Everest Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	106	4,481	2,640	1,651	2,350
Net Total Accounts Receivable
Net Total Receivables	22.6	10.9	19.6	1,687	132
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	131	4,496	2,688	3,414	2,508
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	46.1	122	288	724	685
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,137	7,477	6,646	6,615	5,773
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	504	187	270	870	300
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2,998	636	754	960	804
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	-861	6,841	5,892	5,654	4,969
Total Liabilities & Shareholders' Equity	2,137	7,477	6,646	6,615	5,773
Total Common Shares Outstanding